Qualitative measures that assess functional disability and quality of life in ALS
Abstract Background Selection of appropriate trial endpoints and outcome measures is particularly important in rare disease and rapidly progressing disease such as amyotrophic lateral sclerosis (ALS) where the challenges to conducting clinical trials, are substantial: patient and disease heterogenei...
Main Authors: | Susan L. Hartmaier, Thomas Rhodes, Suzanne F. Cook, Courtney Schlusser, Chao Chen, Steve Han, Neta Zach, Venkatesha Murthy, Shreya Davé |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-01-01
|
Series: | Health and Quality of Life Outcomes |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12955-022-01919-9 |
Similar Items
-
Clinicians’ perspectives of health-related quality of life (HRQoL) implications of amblyopia: a qualitative study
by: Jill Carlton
Published: (2011-08-01) -
Qualitative study to characterize patient experience and relevance of patient-reported outcome measures for patients with metastatic synovial sarcoma
by: Laurie Eliason, et al.
Published: (2022-05-01) -
Structural and diffusion imaging versus clinical assessment to monitor amyotrophic lateral sclerosis
by: Arturo Cardenas-Blanco, et al.
Published: (2016-01-01) -
Patient perspectives on considerations, tradeoffs, and experiences with multiple myeloma treatment selection: a qualitative descriptive study
by: Carrie Dombeck, et al.
Published: (2023-01-01) -
Clinical, economic, and health‐related quality of life outcomes in patients with overweight or obesity in the United States: 2016–2018
by: Joanna P. MacEwan, et al.
Published: (2024-02-01)